How does Bifidobacterium breve CCFM1078 target Rheumatoid Arthritis (RA) by repairing the intestinal barrier?
Views : 16
Update time : 2026-07-17 09:12:00
The core mechanism lies in its ability to effectively upregulate the expression of intestinal tight junction proteins (such as ZO-1 and Occludin), thereby repairing the damaged intestinal mucosal barrier. This barrier-enhancing effect helps reduce intestinal permeability and restricts the translocation of pro-inflammatory substances like lipopolysaccharides (LPS) into the bloodstream. Consequently, it helps modulate the inflammatory cascade along the "gut-joint axis" to support joint health.
This mechanism is supported by rigorous animal studies and patents. In a collagen-induced arthritis rat model, CCFM1078 was shown to reduce joint thickness and morbidity while downregulating pro-inflammatory cytokines (such as TNFα and IL-1β) in the serum. Additionally, it helps reshape the gut microbiome and promotes the production of beneficial bacteria and short-chain fatty acids. Based on these solid scientific findings, this strain has been granted a Chinese invention patent, providing a strong intellectual property barrier for product development.
Leveraging our comprehensive one-stop OEM services, brand owners can easily transform this patented strain into premium joint health supplements, such as capsules and powders. This empowers brands to strategically enter the global immune-regulation market focused on the "gut-joint axis" and create highly competitive, differentiated products.
This mechanism is supported by rigorous animal studies and patents. In a collagen-induced arthritis rat model, CCFM1078 was shown to reduce joint thickness and morbidity while downregulating pro-inflammatory cytokines (such as TNFα and IL-1β) in the serum. Additionally, it helps reshape the gut microbiome and promotes the production of beneficial bacteria and short-chain fatty acids. Based on these solid scientific findings, this strain has been granted a Chinese invention patent, providing a strong intellectual property barrier for product development.
Leveraging our comprehensive one-stop OEM services, brand owners can easily transform this patented strain into premium joint health supplements, such as capsules and powders. This empowers brands to strategically enter the global immune-regulation market focused on the "gut-joint axis" and create highly competitive, differentiated products.
